Fundraising FoxLEUCADIA
1 known investors
Find your way into LEUCADIA
Sign up to see every warm intro you have to LEUCADIA
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LEUCADIA team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Leucadia Therapeutics is developing Arethusta, a first-in-class outpatient treatment for Alzheimer's disease, initially aiming to reverse mild cognitive impairment associated with the condition before targeting prevention and cure. The company operates in the biotech and neurological therapeutics space.
Investors · 1
Frequently asked questions
- What does LEUCADIA do?
- Leucadia Therapeutics is developing Arethusta, a first-in-class outpatient treatment for Alzheimer's disease, initially aiming to reverse mild cognitive impairment associated with the condition before targeting prevention and cure. The company operates in the biotech and neurological therapeutics space.
- Who are LEUCADIA's investors?
- LEUCADIA's investors include Methuselah Funds.